Bayesian response adaptive clinical trials are currently evaluating experimental therapies for several diseases. Adaptive decisions, such as pre-planned variations of the randomization probabilities, attempt to accelerate the development of new treatments. The design of response adaptive trials, in most cases, requires time consuming simulation studies to describe operating characteristics, such as type I/II error rates, across plausible scenarios. We investigate large sample approximations of pivotal operating characteristics in Bayesian Uncertainty directed trial Designs (BUDs). A BUD trial utilizes an explicit metric u to quantify the information accrued during the study on parameters of interest, for example the treatment effects. The randomization probabilities vary during time to minimize the uncertainty summary u at completion of the study. We provide an asymptotic analysis (i) of the allocation of patients to treatment arms and (ii) of the randomization probabilities. For BUDs with outcome distributions belonging to the natural exponential family with quadratic variance function, we illustrate the asymptotic normality of the number of patients assigned to each arm and of the randomization probabilities. We use these results to approximate relevant operating characteristics such as the power of the BUD. We evaluate the accuracy of the approximations through simulations under several scenarios for binary, time-to-event and continuous outcome models.
翻译:适应性临床试验目前正在评估若干疾病的实验治疗方法。适应性决定,例如预计划的随机性概率变化,试图加快新治疗方法的发展。适应性试验的设计,在多数情况下,需要花费时间的模拟研究来描述操作特征,例如一/二型误差率,跨合理假想的操作性特征。我们调查了巴伊西亚不确定性指导试验设计(BUDs)中关键操作特征的大量样本近似值。一个BUD试验使用一个明确的衡量标准来量化在研究兴趣参数(例如治疗效果)期间积累的信息。随机性概率在完成研究时会变化,以尽量减少不确定性摘要。我们提供了一种随机性分析(一)病人在治疗武器上的分配情况,(二)随机性概率。对于属于自然指数型家庭且具有四分异功能的结果分布,我们用一个明确的衡量标准来量化每个手臂的病人人数和随机性概率概率(例如治疗效果)的正常度。我们用这些分析结果来评估BUD连续结果的相关特性。我们用这些精确性来评估BUD结果的精确性。